Clinical trial randomized and controlled to compare the analgesic efficacy of the association zoledronic acid and 153Sm-lexidronam vs zoledronic acid in patients with skeletal metastases from hormono-refractory prostatic neoplasia and moderate-severe bone pain associated [Studio clinico randomizzato e controllato per comparare l'™efficacia analgesica dell'™associazione acido zoledronico e 153Sm-lexidronam verso acido zoledronico in pazienti affetti da metastasi ossee da neoplasia prostatica ormono-refrattaria con dolore associato a cancro di intensita' moderata-severa]

Trial Profile

Clinical trial randomized and controlled to compare the analgesic efficacy of the association zoledronic acid and 153Sm-lexidronam vs zoledronic acid in patients with skeletal metastases from hormono-refractory prostatic neoplasia and moderate-severe bone pain associated [Studio clinico randomizzato e controllato per comparare l'™efficacia analgesica dell'™associazione acido zoledronico e 153Sm-lexidronam verso acido zoledronico in pazienti affetti da metastasi ossee da neoplasia prostatica ormono-refrattaria con dolore associato a cancro di intensita' moderata-severa]

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Oct 2013

At a glance

  • Drugs Samarium-153-SM-lexidronam (Primary) ; Zoledronic acid
  • Indications Cancer pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top